Zhengye Biotechnology logo
Zhengye Biotechnology
ZYBT | NASDAQ
Chart Builder DCF Calculator
$1.43
-$0.07 (-4.67%)
At close: Nov 16, 2026, 4:00 PM ET
$1.43
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:02 PM ET

Zhengye Biotechnology Company Profile

Company profile explained

Company Profile

Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.

Key Executives

Name Position
Aiden Han Co-Chief Executive Officer
Songlin Song Co-Chief Executive Officer
Ping Wang Chief Financial Officer
Zhongyao Liu Chief Operating Officer
Yuhong Cheng Vice General Manager

Latest SEC Filings

Date Type Title
Aug 06, 2026 6-K Filing
Jul 21, 2026 6-K Filing
Jun 25, 2026 3 Filing
Jun 25, 2026 3 Filing
Jun 25, 2026 3 Filing
Jun 25, 2026 3 Filing
Jun 25, 2026 3 Filing
Jun 04, 2026 6-K Filing
Apr 28, 2026 20-F Filing
Apr 24, 2026 3 Filing
View All SEC Filings ➞
Zhengye Biotechnology
Zhengye Biotechnology logo
Country China
IPO Date Jan 7, 2025
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 269
CEO Songlin Song

Contact Details

No.1 Lianmeng Road Jilin, JI 132101 China

Stock Details

Ticker Symbol ZYBT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001975641
CUSIP Number G989MS101
ISIN Number KYG989MS1016
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.